Cited by 307Prostate Cancer Diagnosis and TreatmentMRI in cancer diagnosisMedical Imaging Techniques and Applications

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study

Heesakkers, Roel AM, Hövels, Anke M, Jager, Gerrit J, van den Bosch, Harrie CM, Witjes, J Alfred, Raat, Hein PJ, Severens, Johan L, Adang, Eddy MM, van der Kaa, Christina Hulsbergen, Fütterer, Jurgen J, Barentsz, Jelle·2008·The Lancet Oncology

DOI 10.1016/s1470-2045(08)70203-1

Open this paper in CoChat — free account

Abstract

Background In patients with prostate cancer who are deemed to be at intermediate or high risk of having nodal metastases, invasive diagnostic pelvic lymph-node dissection (PLND) is the gold standard for the detection of nodal disease. However, a new lymph-node-specific MR-contrast agent ferumoxtran-10 can detect metastases in normal-sized nodes (ie, <8 mm in size) by use of MR lymphoangiography (MRL). In this prospective, multicentre cohort study, we aimed to compare the diagnostic accuracy of MRL with up-to-date multidetector CT (MDCT), and test the hypothesis that a negative MRL finding obviates the need for a PLND.Methods We included consecutive patients with prostate cancer who had an intermediate or high risk (risk of >5% according to routinely used nomograms) of having lymph-node metastases. All patients were assessed by MDCT and MRL, and underwent PLND or fine-needle aspiration biopsy. Imaging results were correlated with histopathology. The primary outcomes were sensitivity, specificity, accuracy, NPV, and PPV of MRL and MDCT. This study is registered with ClinicalTrials.gov, number NCT00185029.Findings The study was done in 11 hospitals in the Netherlands between April 8, 2003, and April 19, 2005. 375 consecutive patients were included. 61 of 375 (16%) patients had lymph-node metastases. Sensitivity was 34% (21 of 61; 95% CI 23-48) for MDCT and 82% (50 of 61; 70-90) for MRL (McNemar's test p<0.05). Specificity was 97% (303 of 314; 94-98) for MDCT and 93% (291 of 314; 89-95) for MRL. Positive predictive value (PPV) was 66% (21 of 32; 47-81) for MDCT and 69% (50 of 73; 56-79) for MRL. Negative predictive value (NPV) was 88% (303 of 343; 84-91) for MDCT and 96% (291 of 302; 93-98) for MRL (McNemar's test p<0.05). Of the 61 patients with lymph-node metastases, 50 were detected by MRL, of which 40 (80%) had metastases in normal-sized lymph nodes. The high sensitivity and NPV of MRL imply that in patients with a negative MRL, the chance of positive lymph nodes is less than 11/302 (4%).Interpretation MRL had significantly higher sensitivity and NPV than MDCT for patients with prostate cancer who had intermediate or high risk of having lymph-node metastases. In such patients, after a negative MRL, the post-test probability of having lymph-node metastases is low enough to omit a PLND.

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(08)70203-1

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Self-citation
The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer
Partin, A. W., Yoo, J. J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I., & Walsh, P. C. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35410-1 · Cited by 1,254
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis
Hövels, A. M., Heesakkers, R. A. M., Adang, E., Jager, G. J., Strum, S. B., Hoogeveen, Y. L., Severens, J. L., & Barentsz, J. O. (2008) · Clinical Radiology · doi:10.1016/j.crad.2007.05.022 · Cited by 956
Self-citation
Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Gleason Score (Partin Tables) Based on Cases from 2000 to 2005
Makarov, D. V., Trock, B. J., Humphreys, E. B., Mangold, L. A., Walsh, P. C., Epstein, J. I., & Partin, A. W. (2007) · Urology · doi:10.1016/j.urology.2007.03.042 · Cited by 474
Risk of prostate carcinoma death in patients with lymph node metastasis
Liang Cheng, C., Zincke, H., Blute, M. L., Bergstralh, E. J., Scherer, B. G., & Bostwick, D. G. (2001) · Cancer · doi:10.1002/1097-0142(20010101)91:1 · Cited by 359
Diagnostic Performance of Nanoparticle-Enhanced Magnetic Resonance Imaging in the Diagnosis of Lymph Node Metastases in Patients With Endometrial and Cervical Cancer
Rockall, A., Sohaib, S. A., Harisinghani, M. G., Babar, S. A., Singh, N., Jeyarajah, A., Oram, D. H., Jacobs, I. J., Shepherd, J. H., & Reznek, R. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.166 · Cited by 338
Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis
Will, O., Purkayastha, S., Chan, C., Athanasiou, T., Darzi, A. W., Gedroyc, W. M. W., & Tekkis, P. P. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70537-4 · Cited by 260
Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience.
Bellin, M., Roy, C., Kinkel, K., Thoumas, D., Zaïm, S., Vanel, D., Tuchmann, C., Richard, F., Didier Jacqmin, D., Delcourt, A., et al. (1998) · Radiology · doi:10.1148/radiology.207.3.9609907 · Cited by 259

Show all 40 references

Research works printed but not linked: 1

El Galley, 1998, Evaluation of staging lymphadenectomy in prostate cancer, Urology, 52, 663, 10.1016/S0090-4295(98)00222-2 · DOI

Sorted by citations

Items 201–300 of 305

Comments on Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer, Triantafyllou et al., European journal of cancer, published online 22 October 2012
Fortuin, A. S., & Barentsz, J. O. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.01.023 · Cited by 7
Self-citation
The importance of the extent of pelvic-lymph-node dissection in the diagnosis of lymph-node metastases in prostate cancer
Briganti, A., Rigatti, P., & Montorsi, F. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70242-0 · Cited by 7
The Potential of PET/MRI Imaging in Oncology: a Comment to a Summary Report of the First PET/MRI Workshop in Tuebingen in 2012
Czernin, J. G., & Herrmann, K. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0642-y · Cited by 7
Subnodal Correspondence of PSMA Expression and USPIO-MRI in Metastatic Pelvic Lymph Nodes in Prostate Cancer
Schilham, M. G. M., Somford, D. M., Veltien, A. A., Zámecnik, P., Barentsz, J. O., Sedelaar, J. P. M., Küsters‐Vandevelde, H. V. N., Gotthardt, M., Rijpkema, M., & Scheenen, T. W. J. (2023) · Investigative Radiology · doi:10.1097/rli.0000000000001046 · Cited by 6
Self-citation
Free‐breathing high‐resolution respiratory‐gated radial stack‐of‐stars magnetic resonance imaging of the upper abdomen at 7 T
Maatman, I. T., Schulz, J., Ypma, S., Block, K. T., Schmitter, S., Hermans, J. J., Smit, E. J., Maas, M. C., & Scheenen, T. W. J. (2024) · NMR in Biomedicine · doi:10.1002/nbm.5180 · Cited by 6
Prostate Imaging Modalities that Can Be Used for Complementary and Alternative Medicine Clinical Studies
Dusing, R. W., Drisko, J., Grado, G. G., Levine, M., Holzbeierlein, J. M., & Veldhuizen, P. J. V. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.04.003 · Cited by 6
Nichtinvasive bildgebende Verfahren zum präoperativen axillären Lymphknotenstaging beim Mammakarzinom
Wasser, K., Schnitzer, A., Brade, J., & Schoenberg, S. O. (2010) · Der Radiologe · doi:10.1007/s00117-010-2072-z · Cited by 6
Cancer de la prostate à haut risque de progression. Article de revue du comité de cancérologie de l’association française d’urologie
Rozet, F., Hennequin, C., Fromont, G., Mongiat-Artus, P., Bastide, C., Beuzeboc, P., Cormier, L., Eiss, D., Peyromaure, M., Richaud, P. M., et al. (2011) · The French Journal of Urology · doi:10.1016/j.purol.2011.09.006 · Cited by 6
Comparison of Nodal Risk Formula and MR Lymphography for Predicting Lymph Node Involvement in Prostate Cancer
Deserno, W. M. L. L. G., Debats, O. A., Rozema, T., Fortuin, A. S., Heesakkers, R. A. M., Hoogeveen, Y. L., Peer, P. G. M., Barentsz, J. O., & van Lin, E. N. J. T. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.05.043 · Cited by 6
Self-citation
Bildgebung beim Prostatakarzinom
Attenberger, U. I., Schoenberg, S. O., Weidner, A., Niyazi, M., Bittencourt, L. K., Buergy, D., Sertdemir, M., & Hausmann, D. (2013) · Der Onkologe · doi:10.1007/s00761-013-2484-2 · Cited by 6
Extended robotic salvage lymphadenectomy in patients with "node-only "prostate cancer recurrence: initial experience
Kolontarev, K. B., Говоров, А. В., Kasyan, G. R., Rasner, P., Vasilyev, A. O., & Pushkar, D. (2018) · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · doi:10.5173/ceju.2018.1478 · Cited by 6
Iron Oxide Nanoparticle-Based MRI Contrast Agents: Characterization and In Vivo Use
Herranz, F., Morales, M. P., Rodríguez, I., & Ruíz-Cabello, J. (2016) · Springer eBooks · doi:10.1007/978-3-662-52780-1_3 · Cited by 6
Extent and consequences of lymphadenectomy in oesophageal cancer surgery: case vignette survey
de Gouw, D. J. J. M., Scholte, M., Gisbertz, S. S., Wijnhoven, B. P. L., Rovers, M. M., Klarenbeek, B. R., & Rosman, C. (2020) · BMJ Surgery Interventions & Health Technologies · doi:10.1136/bmjsit-2019-000026 · Cited by 5
In vivo photoacoustic detection of lymph node metastasis using glycol-chitosan-coated gold nanoparticles
Dumani, D. S., Sun, I., & Emelianov, S. (2017) · IEEE International Ultrasonics Symposium · doi:10.1109/ultsym.2017.8091666 · Cited by 5
Medical Applications of Magnetic Nanoparticles
Avolio, M., Innocenti, C., Lascialfari, A., Mariani, M., & Sangregorio, C. (2021) · Springer series in materials science · doi:10.1007/978-3-030-60473-8_14 · Cited by 5
Quel bilan d’imagerie avant une radiothérapie de rattrapage après prostatectomie radicale pour adénocarcinome prostatique ?
Pasquier, D., Hugentobler, A., & Masson, P. (2009) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2009.02.006 · Cited by 5
Diagnostic performance of conventional MRI using T1W and T2W for primary lymph node staging in intermediate- and high-risk prostate cancer patients prior to pelvic lymph node dissection
Daouacher, G., Carlsson, J., Voulgarakis, N., Papageorgiou, S., Dahlman, P., Sundqvist, P., & Waldén, M. (2025) · Abdominal Radiology · doi:10.1007/s00261-025-05073-w · Cited by 4
Role of Lymphadenectomy for Prostate Cancer: Indications and Controversies
Rochelle, J. C. L., & Amling, C. L. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.07.009 · Cited by 4
Future Advances in Diagnosis and Drug Delivery in Interventional Radiology Using MR Imaging–Steered Theranostic Iron Oxide Nanoparticles
Dimov, I. P., Tous, C., Li, N., Häfeli, U. O., Martel, S. M., & Soulez, G. (2021) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2021.05.027 · Cited by 4
Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification
Gennaro, K. H., Porter, K. K., Gordetsky, J., Galgano, S. J., & Rais‐Bahrami, S. (2018) · Diagnostics · doi:10.3390/diagnostics8040080 · Cited by 4
MRI and 11 C acetate PET/CT for prediction of regional lymph node metastasis in newly diagnosed prostate cancer
von Below, C., Wassberg, C., Grzegorek, R., Kullberg, J., Gestblom, C., Sørensen, J., Waldén, M., & Ahlström, H. K. (2018) · Radiology and Oncology · doi:10.2478/raon-2018-0001 · Cited by 4
Validation of In Vivo Nodal Assessment of Solid Malignancies with USPIO-Enhanced MRI: A Workflow Protocol
Driessen, D. A. J. J., de Gouw, D. J. J. M., Stijns, R. C. H., Litjens, G., Israël, B., Philips, B. W. J., Hermans, J. J., Dijkema, T., Klarenbeek, B. R., van der Post, R. S., et al. (2022) · Methods and Protocols · doi:10.3390/mps5020024 · Cited by 4
Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center
Riggs, S. B., & Burks, R. T. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt171 · Cited by 4
Diagnosis and Treatment of Prostate Cancer: What Americans Can Learn From International Oncologists
James, N. D., Graham, J., Maurer, T., Eiber, M. J., & Gschwend, J. E. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175496 · Cited by 3
Pre-prostatic tissue removed in robotic assisted lymph node dissection for prostate cancer contains lymph nodes
Horstmann, M., Blarer, J., Padevit, C., Horton, K. M., Pfofe, D., & John, H. (2013) · Urology Annals · doi:10.4103/0974-7796.120301 · Cited by 3
Evaluation of Lymph Nodes Using DW-MRI
Froehlich, J. M., & Thoeny, H. C. (2010) · Medical radiology · doi:10.1007/978-3-540-78576-7_12 · Cited by 3
Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) in Initial Staging of Prostate Cancer Patients: The Beginning of a New Era
Rivas, J. G., de la Parra, I., Hernández, S. I., Ibáñez, L., Hidalgo, B. G., Cabrera, M. N., Puente, J., Sanmamed, N., Polledo, L. E. O., Romo, I. G., et al. (2025) · Medicina · doi:10.3390/medicina61050924 · Cited by 2
Is pelvic MRI imaging sufficient cross-sectional imaging for staging intermediate and high-risk prostate cancer?
Owens, R. G., Loloi, J., Lehman, E. B., Kaag, M. G., Raman, J. D., & Merrill, S. B. (2021) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2021.01.029 · Cited by 2
The Role of Radiation Therapy in the Management of Prostate Cancer and Posttreatment Imaging Appearances
Ghosh, S., Rosen, D. B., Pandey, A., Nakrour, N., Prajapati, P., Harisinghani, M. G., & Kamran, S. C. (2024) · Journal of Gastrointestinal and Abdominal Radiology · doi:10.1055/s-0044-1782203 · Cited by 2
Magnetic Resonance Imaging of Pelvic Metastases in Male Patients
Abtahi, S. M., Mao, Y. J., Prapruttam, D., Elmi, A., & Hedgire, S. (2014) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2014.01.006 · Cited by 2
Automated multistructure atlas‐assisted detection of lymph nodes using pelvic MR lymphography in prostate cancer patients
Debats, O. A., Meijs, M., Litjens, G. J. S., & Huisman, H. J. (2016) · Medical Physics · doi:10.1118/1.4951726 · Cited by 2
Preoperative Stating of Pelvic Lymph Nodes in Prostate Cancer Patients via Endorectal Magnetic Resonance Imaging
Zugor, V., von Brandenstein, M., Akbarov, I., Porres, D., Kühn, R., & Labanaris, A. P. (2018) · Anticancer Research · doi:10.21873/anticanres.12413 · Cited by 2
MRI of Prostate Cancer
Kritikos, N. V. (2018) · Springer eBooks · doi:10.1007/978-3-319-68873-2_89 · Cited by 2
Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost
Shortall, J., Osorio, E. M. V., Green, A., McWilliam, A., Elumalai, T., Reeves, K. J., Johnson‐Hart, C., Beasley, W. J., Hoskin, P., Choudhury, A., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1200676 · Cited by 2
Value of diffusion weighted magnetic resonance imaging in the prediction of cancer prostate
Afifi, A. H., Ettaby, A. N., Ahmad, M. A. Y., & Farghaly, Y. T. (2012) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2012.08.008 · Cited by 2
Radio‐Labeled Nanoparticles for Biomedical Imaging
Aweda, T. A., Sultan, D. H., & Liu, Y. (2014) · Wiley eBooks · doi:10.1002/9781118873151.ch7 · Cited by 2
Imaging
Richenberg, J. (2014) · Prostate Cancer · doi:10.1002/9781118347379.ch5 · Cited by 2
Nanomedicines in ischemic cardiovascular and cerebrovascular diseases: Theranostic technologies based on reactive oxygen species
Cui, X., Qu, P., Zhang, X., Guo, W., Luo, H., Qu, H., Zhang, H., Li, H., Fu, C., Yu, Z., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115050 · Cited by 1
Bildgebende Diagnostik des fortgeschrittenen Prostatakarzinoms
Kretschmer, A., Seitz, M., Graser, A., Stief, C. G., & Derya Tilki, A. (2013) · Der Urologe · doi:10.1007/s00120-012-3095-z · Cited by 1
Salvage lymphadenectomy in patients with recurrent prostate cancer after radical prostatectomy A.O. Vasil’ev, A.V. Govorov, D.Yu. Pushkar’
Vasilyev, A. O., Говоров, А. В., & DIu, P. (2017) · Cancer Urology · doi:10.17650/1726-9776-2017-13-2-174-188 · Cited by 1
Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by 11C-Choline PET/CT
Kitajima, K., Yamamoto, S., Odawara, S., Kawanaka, Y., Nakanishi, Y., Hashimoto, T., Yamada, Y., Suzuki, T., Kanematsu, A., Nojima, M., et al. (2018) · Case Reports in Oncology · doi:10.1159/000486365 · Cited by 1
Prostate Imaging
Elbuluk, O., Türkbey, B., & Choyke, P. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-23464-9_4 · Cited by 1
Nodal disease assessment in pelvic malignancy
ALLOUNI, A. K., Sarkodieh, J. E., & Rockall, A. (2013) · Imaging · doi:10.1259/imaging.20120016 · Cited by 1
18F‐Fluorocholine PET/CT in prostate cancer initial staging
Lapa, P. A. A., Silva, R., Saraiva, T., Figueiredo, A., Ferreira, R. C., Costa, G., & Lima, J. P. (2016) · Acta Urológica Portuguesa · doi:10.1016/j.acup.2016.04.003 · Cited by 1
Radical Prostatectomy and Lymphadenectomy in the High-Risk Prostate Cancer: Surgical Technique, Functional and Oncologic Outcomes
Şahın, H., & Deliktaş, H. (2015) · Bulletin of Urooncology · doi:10.4274/uob.324 · Cited by 1
ADVANCES IN THE IMAGING OF THE PROSTATE IN THE SETTING OF ELEVATED PSA LEVELS
Hicks, R. J., Parameswaran, B. K., Hofman, M. S., Murphy, D. G., Lawrentschuk, N., & Williams, S. (2015) · Cited by 1
Current Role of Magnetic Resonance Imaging in Prostate Cancer
Mehralivand, S., Sidana, A., Maruf, M., Choyke, P. L., Pinto, P. A., & Türkbey, B. (2017) · Current Radiology Reports · doi:10.1007/s40134-017-0255-3 · Cited by 1
Collapsin response mediator protein 4 promotor methylation level as a potential predictor for diagnosing primary malignant lymphoma of the prostate
Chen, Z., Liang, Q., Wang, J., Huang, Q., Chen, J., Weng, Z., Shao, C., Gao, X., & Pang, J. (2018) · Cancer Cell International · doi:10.1186/s12935-017-0484-9 · Cited by 1
Radiological contrast agents and radiopharmaceuticals
Olliff, J. F. C., & Riley, P. L. (2012) · Side effects of drugs annual · doi:10.1016/b978-0-444-59499-0.00046-5 · Cited by 1
Magnetic Resonance Imaging of Prostate Cancer
Barentsz, J. O., Heijmink, S. W. T. P. J., der Kaa, C. H.-V., Hoeks, C. M. A., & Fütterer, J. J. (2010) · Springer eBooks · doi:10.1007/978-88-470-1637-8_18 · Cited by 1
Self-citation
Prostate Cancer
van Vulpen, M. (2010) · Medical radiology · doi:10.1007/174_2010_74 · Cited by 1
Pelvic Lymphadenectomy for Localised Prostate Cancer and Robot-Assisted Radical Prostatectomy
Schwab, C., & John, H. A. (2013) · Springer eBooks · doi:10.1007/978-3-642-33215-9_9
La PET/TC con (11)C-Colina en el Cáncer de Próstata
Garzón, G., & de Ramón, J. R. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The Contribution of Diagnostic Imaging in Rare Gynaecological Malignancies
Connor, R. (2010) · Springer eBooks · doi:10.1007/978-3-642-13492-0_4
The clinically negative neck in oral squamous cell carcinoma: an update on preoperative imaging and follow-up
Wensing, B. M. (2012) · Radboud Repository (Radboud University)
Diagnosis and Management of Metastatic Prostate Cancer
TOMBAL, B. F., & Lecouvet, F. E. (2014) · Prostate Cancer · doi:10.1002/9781118347379.ch13
[High-risk clinically localised prostate cancer].
Rozet, F., Cornu, J.-N., Cussenot, O., Fromont, G., & Hennequin, C. (2010) · PubMed · doi:10.1684/bdc.2010.1228
Indications for Pelvic Lymphadenectomy
Raman, J. D., & Gherezghihir, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800077-9.00028-1
Axillary and internal mammary sentinel node biopsy in breast cancer : studies on technical aspects, clinical implications and outcome
Heuts, E. M. (2009) · doi:10.26481/dis.20090702eh
Hybrid Imaging: From Anatomy to Function
Juan, D. G., Trombella, S., & Ratib, O. M. (2013) · Springer eBooks · doi:10.1007/978-1-4471-6275-9_3
Magnetic Resonance Sentinel Lymph Node Detection in Prostate Cancer
Rosenkrantz, A. B., & Taneja, S. S. (2015) · Academic Radiology · doi:10.1016/j.acra.2015.02.007
Técnicas, indicaciones y resultados del vaciamiento ganglionar en el tratamiento del cáncer de próstata
Richard, P. O., & Bladou, F. (2014) · EMC - Urología · doi:10.1016/s1761-3310(14)66859-6
New Imaging Modalities
Cho, S. Y., Dianat, S. S., & Macura, K. J. (2014) · Current clinical urology · doi:10.1007/978-1-4939-1176-9_4
Detection of lymph node metastases by photoacoustic imaging
Grootendorst, D. J. (2013) · doi:10.3990/1.9789036535106
The Role of MRI in the Diagnosis of the Lung Cancers and Mediastinal Tumors
Nasu, K. (2012) · Haigan · doi:10.2482/haigan.52.326
Archive of SID Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer
Barar, J., & Omidi, Y. (2014)
A Review of Techniques for Sentinel Lymph Node Mapping with Special Reference to the Head and Neck Region
Sun, J. (2016) · International Clinical Pathology Journal · doi:10.15406/icpjl.2016.02.00037
Sentinel lymph Node Detection during Radical Prostatectomy for Prostate Cancer: Current Evidence and Results of Our Experience
Marchioro, G., Gontero, P., Angelis, P. D., Volpe, A., Frea, B., & Terrone, C. (2016) · Urologia Journal · doi:10.5301/uro.5000181
Clinical Experience with Nanoparticles in Imaging
Sutphin, P. D., & Harisinghani, M. G. (2014) · Frontiers in nanobiomedical research · doi:10.1142/9789814520652_0050
Pelvic Lymph Node Dissection: Open Benchmarks with Lymphoscintigraphy
Nguyen, D. P., Huber, P. M., Metzger, T. A., Zehnder, P., & Thalmann, G. N. (2016) · Springer eBooks · doi:10.1007/978-3-319-32641-2_14
PET and MRI of Prostate Cancer
von Below, C. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Prostate Cancer Imaging: An Ongoing Change of Paradigm
Rouvière, O., & Champagnac, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-42769-0_7
Nanotechnology
Watts, K. L., & Stern, J. M. (2017) · Wiley eBooks · doi:10.1002/9781118868126.ch15
Radiological contrast agents and radiopharmaceuticals
Olliff, J. F. C., & Riley, P. L. (2011) · Side effects of drugs annual · doi:10.1016/b978-0-444-53741-6.00046-5
Comparison of CT and Optical Image-based Assessment of Liposome Distribution
Huang (2012) · TSpace (University of Toronto)
Pelvic Lymph Node Dissection for Prostate Cancer and Nomograms
Zaffuto, E., Gandaglia, G., Fossati, N., Montorsi, F., & Briganti, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-20645-5_23
Possible Role of Ga-68 PSMA PET/CT in Evaluation of Systemic Treatment Response in Patients with Metastatic Prostate Cancer
Sivrikoz, İ. A. (2018) · Nuclear Medicine Seminars · doi:10.4274/nts.2018.026
Apport du 68Ga-PSMA-TEP dans la prise en charge initiale par radiothérapie des cancers de la prostate
Karahissarlian, V., Pommier, P., & Isnardi, V. (2019) · Médecine Nucléaire · doi:10.1016/j.mednuc.2019.04.002
SAVING LYMPHADENECTOMY IN PATIENTS WITH RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY
Васильев, А. О., Govorov, A., & Pushkar, D. (2017) · Voprosy Onkologii · doi:10.37469/0507-3758-2017-63-1-62-68
Spicing up prostate cancer theranostics
van Kalmthout, L. W. M. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/334
18F-PSMA-1007 PET/CT in Primary Prostate Cancer: Using tPSA to Detect Distant Metastasis and Incorporating SUVmax to Characterize Primary Prostate Cancer and Distant MetastasisPreprint
Wang, Z., Zheng, A., Dong, W., Liu, X., Wang, Y., Gao, F., & Duan, X. (2021) · Research Square · doi:10.21203/rs.3.rs-201417/v1
Functionele en oncologische uitkomsten van salvage cryochirurgie voor lokaal recidief prostaatcarcinoom na radiotherapie
Nuijens, S. T., Exterkate, L., Dijkstra, S., Peters, M., Somford, D. M., & VERGUNST, H. (2021) · Tijdschrift voor Urologie · doi:10.1007/s13629-021-00340-z
Seeing the Complete Picture: Imaging in Prostate Cancer
Southcombe, L. (2020) · EMJ Urology · doi:10.33590/emjurol/20f0903
Pelvic Lymphadenectomy
Lucas, S., & Sundaram, C. P. (2012) · Wiley eBooks · doi:10.1002/9781444345148.ch77
Prostate Cancer
Peters, M., Maenhout, M., Frank, S. J., & van Vulpen, M. (2016) · Medical radiology · doi:10.1007/174_2016_56
Peer Review #2 of "Intranodal signal suppression in pelvic MR lymphography of prostate cancer patients: a quantitative comparison of ferumoxtran-10 and ferumoxytol (v0.1)"
(2016) · PeerJ · doi:10.7287/peerj.2471v0.1/reviews/2
CONSTITUTIONAL MEDICINE
(1936) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1936.tb102819.x
MRL can accurately detect nodal metastases in patients with prostate cancer
(2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1267
External iliac lymph nodes
Nash, C., Walizai, T., & Hacking, C. (2018) · Radiopaedia.org · doi:10.53347/rid-61266
Peer Review #2 of "Intranodal signal suppression in pelvic MR lymphography of prostate cancer patients: a quantitative comparison of ferumoxtran-10 and ferumoxytol (v0.2)"
(2016) · PeerJ · doi:10.7287/peerj.2471v0.2/reviews/2
Iron Nanoparticles as Magnetic Resonance Imaging Contrast Agents
Ferguson, P. M. (2011) · doi:10.26686/wgtn.17011418
Invited Commentary
Hosseinzadeh, K. (2009) · Radiographics · doi:10.1148/radiographics.29.4.0291069
Peer Review #1 of "Intranodal signal suppression in pelvic MR lymphography of prostate cancer patients: a quantitative comparison of ferumoxtran-10 and ferumoxytol (v0.1)"
(2016) · PeerJ · doi:10.7287/peerj.2471v0.1/reviews/1
The value of 68Ga-PSMA-11 PET/CT in patients with prostate cancer and inconclusive standard imaging at primary staging
Nalliah, S., & Zacho, H. D. (2022) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001602
Application of Magnetic Colloids in Hydrogels for Tissue Engineering
Rivera-Llabres, V. G., Gentry, K., & Rinaldi, C. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781839169755-00410
18F-Fluciclovine
Pirisino, R., Bagni, O., Schillaci, O., & Filippi, L. (2024) · Springer eBooks · doi:10.1007/978-3-031-54196-4_14
Utilidad de la PET/TC con [18F]F-fluorocolina en la valoración de respuesta a la terapia antiandrogénica en pacientes con cáncer de próstata
Quintero, K., Vila, E., Ferrer‐Mileo, L., Vas, D., Ribal, M. J., Garcia-Herreros, M., Navarro, N., Tormo-Ratera, M., Aversa, C., Vilaseca, A., et al. (2024) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2024.500083
"Utility of PET/CT with [18F] F-fluorocholine in assessing the response to antiandrogenic therapy in patients with prostate cancer."
Quintero, K., Vila, E., Ferrer‐Mileo, L., Vas, D., Ribal, M. J., Garcia-Herreros, M., Navarro, N., Tormo-Ratera, M., Aversa, C., Vilaseca, A., et al. (2025) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2025.500083
Prostate dose escalation may positively impact survival in patients with clinically node-positive prostate cancer definitively treated by radiotherapy: surveillance study of the Japanese Radiation Oncology Study Group (JROSG)
Maebayashi, T., Mizowaki, T., Ishikawa, H., Nakamura, K., Inaba, K., Asakura, H., Iwata, H., Itasaka, S., Wada, H., Sakaguchi, M., et al. (2025) · Journal of Radiation Research · doi:10.1093/jrr/rraf005
PET/MRI in the Early Diagnosis of Extra-Nodal Primary Colonic Lymphoma: A Rare Case PresentationPreprint
Shinkar, P. G., Likhitha, S., Dayal, M., Kumar, D., Damerla, C. K., Vamsy, M., & Wadhwa, P. (2025) · Research Square · doi:10.21203/rs.3.rs-6404631/v1

Authors: Heesakkers, R. A., Hövels, A. M., Jager, G. J., van den Bosch, H. C., Witjes, J. A., Raat, H. P., Severens, J. L., Adang, E. M., van der Kaa, C. H., Fütterer, J. J., & Barentsz, J.
Affiliations: Radboud University Medical Center (NL)
Jeroen Bosch Ziekenhuis (NL)
ZorgSaam (NL)
Maastricht University Medical Centre (NL)
Corresponding author: Barentsz, Jelle
ORCID: Hövels, Anke M
Witjes, J Alfred
Raat, Hein PJ
Severens, Johan L
Adang, Eddy MM
Fütterer, Jurgen J
Barentsz, Jelle
Venue: The Lancet Oncology
Publisher: Elsevier BV
Published: 2008-09
Volume: 9
Issue: 9
Pages: 850-856
ISSN: 1470-2045 (ISSN-L)
DOI: 10.1016/s1470-2045(08)70203-1
OpenAlex: W2124586180
Cited by: 307
References: 40
Citations by year: 2026: 2 · 2025: 7 · 2024: 6 · 2023: 9 · 2022: 13 · 2021: 10 · 2020: 16 · 2019: 21 · 2018: 22 · 2017: 19 · 2016: 22 · 2015: 19 · 2014: 21 · 2013: 27 · 2012: 26
FWCI: 19.89
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Lancet Oncology (publishedVersion)
PubMed (publishedVersion)
Radboud Repository (Radboud University) (submittedVersion)
Funders: Radboud Universiteit
Topics: Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords: prostate cancer, pelvic lymph node metastasis, MR lymphography, ferumoxtran-10, pelvic lymphadenectomy, multidetector computed tomography, diagnostic accuracy, intermediate- and high-risk prostate cancer, fine-needle aspiration, lymph node staging, negative predictive value, sensitivity and specificity, cost-effectiveness, quality of life
MeSH terms: Aged, Aged, 80 and over, Contrast Media, Dextrans, Humans, Iron, Lymph Node Excision, Lymphatic Metastasis, Male, Middle Aged, Oxides, Predictive Value of Tests, Prostatic Neoplasms, Sensitivity and Specificity, Tomography, X-Ray Computed, Echo-Planar Imaging, Ferrosoferric Oxide, Magnetite Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks